Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Emerg Med ; 38(11): 2487.e1-2487.e5, 2020 11.
Article in English | MEDLINE | ID: mdl-32532617

ABSTRACT

Millions of people worldwide use nutritional and dietary supplements, such as vitamins and minerals. These and other performance-enhancing substances are also used by high school, college, and professional athletes, bodybuilders, and amateur sports enthusiasts. The constituents of these supplements and their metabolites may be harmful and not listed on the product label. We present a case report of a 32-year-old bodybuilder using myriad nutritional, performance-enhancing, and weight-loss supplements with life-threatening encephalopathy, hepatic failure, rhabdomyolysis, and copper toxicity mimicking Wilson's disease. Emergency physicians and nurses should be aware of these potential deleterious effects and inquire about supplement use by patients with unexplained multiorgan failure. Family, friends, or acquaintances should be asked to bring the actual products to the hospital for analysis.


Subject(s)
Anti-Obesity Agents/poisoning , Brain Diseases/chemically induced , Chemical and Drug Induced Liver Injury/etiology , Copper/poisoning , Dietary Supplements/poisoning , Liver Failure, Acute/chemically induced , Performance-Enhancing Substances/poisoning , Rhabdomyolysis/chemically induced , Trace Elements/poisoning , Adult , Creatine Kinase/metabolism , Diagnosis, Differential , Hepatolenticular Degeneration/diagnosis , Humans , Liver Failure, Acute/metabolism , Liver Function Tests , Male , Rhabdomyolysis/metabolism , Weight Lifting
2.
Mil Med ; 185(1-2): e61-e67, 2020 02 12.
Article in English | MEDLINE | ID: mdl-31670370

ABSTRACT

INTRODUCTION: Carbon monoxide (CO) is produced from incomplete combustion of hydrocarbons and is a by-product of tobacco smoking. Chronic cigarette smokers often have carboxyhemoglobin (COHb) concentrations as high as 10%. We report a case of severely elevated COHb and polycythemia because of tobacco smoking and provide a review of the literature regarding elevated COHb in smokers. MATERIALS AND METHODS: A comprehensive search of PubMed and Google Scholar was performed looking for articles on tobacco smoking and CO, COHb, CO poisoning, cigarettes, pipes, cigars and water pipes/hookah smokers. RESULT: COHb levels in frequent cigarette smokers generally range from 4.2% presmoking to 8.6% postsmoking. A heavy cigarette smoker presented twice with symptoms of CO toxicity and was found to have levels 21.8 to 24.2%. Cigar smokers have been found to have COHb ranging as high as 13.0 to 38.6% in case reports. Waterpipe or "hookah" smokers generally have COHb levels 10.1% +/-2.5% and case reports, and series of even higher levels associated with CO toxicity symptoms are common. Waterpipe smokers have been found to have COHb levels as high as 39.2% after smoking. CONCLUSIONS: Many active duty military and military veterans are tobacco smokers and these patients and their health care providers should be aware of the adverse effects of CO toxicity from tobacco smoking. Patients may have symptoms such as headaches, syncope, and ataxia in the setting of acute CO toxicity; however, the chronic effects of CO may not be completely understood. Future work could explore chronic CO toxicity and its effects on strength and exercise tolerance in military personnel and provide education to service members, veterans, and health care providers.


Subject(s)
Tobacco Smoking , Carbon Monoxide/toxicity , Carboxyhemoglobin , Humans , Smoking/adverse effects
3.
MMWR Morb Mortal Wkly Rep ; 66(21): 549-553, 2017 Jun 02.
Article in English | MEDLINE | ID: mdl-28570504

ABSTRACT

Amanita phalloides, colloquially known as the "death cap," belongs to the Phalloideae section of the Amanita family of mushrooms and is responsible for most deaths following ingestion of foraged mushrooms worldwide (1). On November 28, 2016, members of the Bay Area Mycological Society notified personnel at the California Poison Control System (CPCS) of an unusually large A. phalloides bloom in the greater San Francisco Bay Area, coincident with the abundant rainfall and recent warm weather. Five days later, CPCS received notification of the first human A. phalloides poisoning of the season. Over the following 2 weeks, CPCS was notified of an additional 13 cases of hepatotoxicity resulting from A. phalloides ingestion. In the past few years before this outbreak, CPCS received reports of only a few mushroom poisoning cases per year. A summary of 14 reported cases is presented here. Data extracted from patient medical charts revealed a pattern of delayed gastrointestinal manifestations of intoxication leading to dehydration and hepatotoxicity. Three patients received liver transplants and all but one recovered completely. The morbidity and potential lethality associated with A. phalloides ingestion are serious public health concerns and warrant medical provider education and dissemination of information cautioning against consuming foraged wild mushrooms.


Subject(s)
Mushroom Poisoning/diagnosis , Adult , Aged, 80 and over , Amanita , California , Female , Humans , Infant , Male , Middle Aged , Mushroom Poisoning/therapy , Young Adult
4.
J Comp Neurol ; 496(3): 406-21, 2006 May 20.
Article in English | MEDLINE | ID: mdl-16566002

ABSTRACT

In this study, the peptide VYRKPPFNGSIFamide (Val(1)-SIFamide) was identified in the stomatogastric nervous system (STNS) of the American lobster, Homarus americanus, using matrix-assisted laser desorption/ionization-Fourier transform mass spectrometry (MALDI-FTMS). When bath-applied to the stomatogastric ganglion (STG), synthetic Val(1)-SIFamide activated the pyloric motor pattern, increasing both burst amplitude and duration in the pyloric dilator (PD) neurons. To determine the distribution of this novel SIFamide isoform within the lobster STNS and neuroendocrine organs, a rabbit polyclonal antibody was generated against synthetic Val(1)-SIFamide. Whole-mount immunolabeling with this antibody showed that this peptide is widely distributed within the STNS, including extensive neuropil staining in the STG and commissural ganglia (CoGs) as well as immunopositive somata in the CoGs and the oesophageal ganglion. Labeling was also occasionally seen in the pericardial organ (PO), but not in the sinus gland. When present in the PO, labeling was restricted to fibers-of-passage and was never seen in release terminals. Adsorption of the antibody by either Val(1)-SIFamide or Gly(1)-SIFamide abolished all Val(1)-SIFamide staining within the STNS, including the STG neuropil, whereas adsorption by other lobster neuropeptides had no effect on immunolabeling. These data strongly suggest that the staining we report is a true reflection of the distribution of this peptide in the STNS. Collectively, our mass spectrometric, physiological, and anatomical data are consistent with Val(1)-SIFamide serving as a locally released neuromodulator in the lobster STG. Thus, our study provides the first direct demonstration of function for an SIFamide isoform in any species.


Subject(s)
Digestive System/innervation , Nephropidae/metabolism , Nervous System Physiological Phenomena , Nervous System/metabolism , Neurons/physiology , Neuropeptides/metabolism , Animals , Digestive System/drug effects , Ganglia, Invertebrate/metabolism , Immunohistochemistry/methods , In Vitro Techniques , Models, Neurological , Nephropidae/anatomy & histology , Nervous System Physiological Phenomena/drug effects , Neurons/drug effects , Neuropeptides/isolation & purification , Neuropeptides/pharmacology , Neurosecretory Systems/metabolism , Pyloric Antrum/drug effects , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...